Hamel Associates, Inc. Bristol Myers Squibb CO Transaction History

Hamel Associates, Inc.

$315 Million
Q2 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 03, 2023	SELL	$57.89 - $64.73 $76,704 - $85,767	-1,325 Reduced 27.25%	3,537 $205,000
Q2 2023 Aug 08, 2023	SELL	$63.71 - $70.74 $66,895 - $74,277	-1,050 Reduced 17.76%	4,862 $310,000
Q4 2022 Feb 06, 2023	SELL	$68.48 - $81.09 $40,403 - $47,843	-590 Reduced 9.07%	5,912 $425,000
Q3 2022 Nov 09, 2022	BUY	$0.13 - $76.84 $26 - $15,752	205 Added 3.26%	6,502 $462,000
Q2 2022 Aug 08, 2022	BUY	$72.62 - $79.98 $27,958 - $30,792	385 Added 6.51%	6,297 $485,000
Q1 2022 May 06, 2022	SELL	$61.48 - $73.72 $7,439 - $8,920	-121 Reduced 2.01%	5,912 $432,000
Q4 2021 Feb 08, 2022	SELL	$53.63 - $62.52 $38,828 - $45,264	-724 Reduced 10.71%	6,033 $376,000
Q3 2021 Nov 08, 2021	BUY	$59.17 - $69.31 $59 - $69	1 Added 0.01%	6,757 $400,000
Q2 2021 Aug 04, 2021	SELL	$61.91 - $67.42 $9,286 - $10,113	-150 Reduced 2.17%	6,756 $451,000
Q1 2021 May 04, 2021	BUY	$59.34 - $66.74 $59 - $66	1 Added 0.01%	6,906 $436,000
Q4 2020 Feb 11, 2021	SELL	$57.74 - $65.43 $58,201 - $65,953	-1,008 Reduced 12.74%	6,905 $428,000
Q2 2020 Aug 10, 2020	BUY	$54.82 - $64.09 $54 - $64	1 Added 0.01%	7,913 $465,000
Q1 2020 May 07, 2020	SELL	$46.4 - $67.43 $46,353 - $67,362	-999 Reduced 11.21%	7,912 $441,000
Q4 2019 Feb 12, 2020	BUY	$49.21 - $64.19 $57,132 - $74,524	1,161 Added 14.98%	8,911 $572,000
Q3 2019 Nov 12, 2019	BUY	$42.77 - $50.71 $42 - $50	1 Added 0.01%	7,750 $393,000
Q2 2019 Aug 05, 2019	SELL	$44.62 - $49.34 $54,614 - $60,392	-1,224 Reduced 13.64%	7,749 $351,000
Q1 2019 May 01, 2019	SELL	$45.12 - $53.8 $920,402 - $1.1 Million	-20,399 Reduced 69.45%	8,973 $428,000
Q4 2018 Feb 08, 2019	BUY	$48.76 - $63.23 $48 - $63	1 Added 0.0%	29,372 $1.53 Million
Q3 2018 Oct 25, 2018	SELL	$55.19 - $62.25 $40,012 - $45,131	-725 Reduced 2.41%	29,371 $1.82 Million
Q2 2018 Aug 10, 2018	SELL	$50.53 - $62.98 $231,124 - $288,070	-4,574 Reduced 13.19%	30,096 $1.67 Million
Q1 2018 May 03, 2018	SELL	$59.92 - $68.98 $1.2 Million - $1.38 Million	-20,024 Reduced 36.61%	34,670 $2.19 Million
Q4 2017 Feb 13, 2018	BUY	$59.94 - $65.35 $59 - $65	1 Added 0.0%	54,694 $3.35 Million
Q2 2017 Aug 11, 2017	BUY	N/A	54,693	54,693 $3.05 Million

Others Institutions Holding BMY

# of Institutions

2,428

Shares Held

1.5B

Call Options Held

29.7M

Put Options Held

32.2M

Vanguard Group Inc Valley Forge, PA

187M
Shares

$9.92 Billion
0.15% of portfolio
Black Rock Inc. New York, NY

159M
Shares

$8.44 Billion
0.15% of portfolio
State Street Corp Boston, MA

91.4M
Shares

$4.86 Billion
0.17% of portfolio
Jpmorgan Chase & CO New York, NY

74.6M
Shares

$3.97 Billion
0.27% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

59.1M
Shares

$3.14 Billion
0.47% of portfolio

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hamel Associates, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Hamel Associates, Inc. with notifications on news.

Account